About one-fifth of women, less than 7 percent of men report use of indoor tanning

December 20, 2010

Women are more likely to report use of indoor tanning facilities than men, and some characteristics common to indoor tanners differ by sex, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. However, few tanners--male or female--mention avoiding tanning beds when asked about ways to reduce skin cancer risk.

"Skin cancer is the most common form of malignancy in the United States. The American Cancer Society estimated that 1 million new cases of melanoma and non-melanoma skin cancer were diagnosed in 2009; 8,650 deaths were attributable to melanoma skin cancer," the authors write as background information in the article. "Despite a recent meta-analysis that supported a positive association between increased use of indoor tanning and both melanoma and non-melanoma skin cancers, the indoor tanning industry is still growing rapidly, generating more than $5 billion in annual revenues, and has attracted more than 30 million patrons, primarily women."

To describe the prevalence and characteristics of indoor tanning among U.S. adults, Kelvin Choi, Ph.D., of the University of Minnesota, Minneapolis, and colleagues analyzed data from the Health Information National Trends study, conducted in 2005. A total of 2,869 participants who were white and age 18 to 64 answered questions about demographics, lifestyle factors and their use of indoor tanning. A subset of 821 participants was also asked about skin cancer prevention knowledge and attitudes.

Overall, 18.1 percent of women and 6.3 percent of men reported using indoor tanning facilities during the previous 12 months. Women who tanned were more likely to live in the Midwest or South and also use spray tanning products, whereas those who did not report using indoor tanning were older, had less education, earned lower incomes and used sunscreen regularly. Men were less likely to report indoor tanning if they were older and obese and more likely to do so if they used spray tanning products and lived in metropolitan areas.

"The association between spray tanning product use and indoor tanning use in the past 12 months was strong in women and men, significantly more so in men," the authors write. "Our finding suggests that, instead of substitution, women and men use both means to obtain a tan-looking appearance."

When asked in an open-response format about ways to prevent skin cancer, the most commonly suggested method by both women and men was wearing sunscreen, followed by avoiding the sun and wearing a hat. Only 13.3 percent of women and 4.2 percent of men suggested avoiding tanning bed use. In addition, 5.8 of women and 5.6 percent of men reported that they should be evaluated for skin cancer.

"It is concerning that only a small proportion of adults reported avoidance of indoor tanning bed use to prevent skin cancer," the authors write. "Perhaps people are confused by the messages from the indoor tanning industry on possible benefits of indoor tanning, e.g. getting vitamin D from moderate exposure to artificial UV radiation. This possibility is also suggested by the fact that women and men who suggested sunscreen use as a method to reduce their skin cancer risk were more likely to have tanned indoors."

"Strategies such as clinician-patient communication and media campaigns that focus on strategically disseminating the harms of indoor tanning to the adult population may be needed to reduce the prevalence of indoor tanning among adults in the United States," they conclude.
-end-
(Arch Dermatol. 2010;146[12]:1356-1361. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: This study was supported by the National Cancer Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact Kelvin Choi, Ph.D., call Nick Hanson at 612-624-2449 or e-mail hans2853@umn.edu.

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.

The JAMA Network Journals

Related Melanoma Articles from Brightsurf:

Boosting treatments for metastatic melanoma
University of Cincinnati clinician-scientist Soma Sengupta, MD, PhD, says that new findings from her and Daniel Pomeranz Krummel's, PhD, team might have identified a treatment-boosting drug to enhance effectiveness of therapies for metastatic cancer and make them less toxic, giving patients a fighting chance at survival and improved quality of life.

A promising new tool in the fight against melanoma
An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

New targets for melanoma treatment
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.

Innovative smartphone-camera adaptation images melanoma and non-melanoma
An article published in the Journal of Biomedical Optics (JBO), ''Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring,'' shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer.

Antihistamines may help patients with malignant melanoma
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma?

Blood test for deadly eye melanoma
A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.

Analysis of melanoma in US by age groups
This study used registry data to determine annual rates of melanoma in pediatric, adolescent, young adult and adult age groups, and the findings suggest an apparent decrease among adolescent and young adults between 2006 and 2015 but increases in older adults.

Vitamin D dials down the aggression in melanoma cells
Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found.

B cells linked to immunotherapy for melanoma
Immunotherapy uses our body's own immune system to fight cancer.

Five things to know about melanoma
'Five things to know about ... melanoma' in CMAJ (Canadian Medical Association Journal) provides a brief overview of this malignant skin cancer for physicians and patients.

Read More: Melanoma News and Melanoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.